Alloplex Biotherapeutics: Funding, Investors & Team (Sep 2026)
In order to create a potent anti-tumor vaccination, Alloplex Biotherapeutics is committed to examining the higher order combinatorial space of immunomodulators. This method works with all tumour types and is especially well-suited for use in conjunction with checkpoint inhibitors. Private startup Alloplex is currently funded by angel financing.
Alloplex Biotherapeutics has raised $21.0M across 2 funding rounds on record, the most recent a Series A of $20.0M announced in Feb 2023.
That round is above the $8.0M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
Alloplex Biotherapeutics Company Profile and Key Stats
Latest funding round on record: Feb 2023.
Alloplex Biotherapeutics Funding Rounds
Alloplex Biotherapeutics raised $1.0M in a Corporate Round announced in Aug 2021.
1.5 years later, a Series A of $20.0M was announced in Feb 2023.
Alloplex Biotherapeutics Founders and Leadership Team
Contact details for the Alloplex Biotherapeutics team: 1 of 1 has an email address on file.
Start 14-day free trial →Alloplex Biotherapeutics Funding Compared to Other Biotechnology Startups
Alloplex Biotherapeutics' latest round of $20.0M is above the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Alloplex Biotherapeutics in Biotechnology and Boston
Companies Similar to Alloplex Biotherapeutics
Superluminal Medicines is a biotech company that specializes in rapidly developing new drugs through a…
Senticell's mission is to fully harness the unique immune and genetic functions of RBC to transform and treat…
ImmunoPhotonics, Inc. develops immunotherapy-based treatments for cancer. ImmunoPhotonics, Inc. has a…
EIT Pharma is a commercial-stage biotechnology company focuses on developing and commercializing…
Halia Therapeutics is a biopharmaceutical company in the preclinical stage that is developing new treatments…
Noveome Biotherapeutics, Inc. is an advanced biopharmaceutical company that focuses on groundbreaking…
XiltriX North America is an information technology company that specializes in monitoring, predictive…
Novir is an emerging diagnostic biotechnology company with an unmatched team of professionals and trusted…
Abcuro’s mission is to develop a new class of immune-modulatory bio-therapeutics for treating both…
Georgiamune Inc. is a privately-owned biotechnology company that specializes in advanced immunotherapy…
Bridge to Life was founded with the mission of improving organ transplants by licensing and developing new…
InduPro is a biotechnology firm that focuses on protein therapeutics and technologies related to cell-surface…
Alloplex Biotherapeutics Funding FAQs
What does Alloplex Biotherapeutics do?
In order to create a potent anti-tumor vaccination, Alloplex Biotherapeutics is committed to examining the higher order combinatorial space of immunomodulators. This method works with all tumour types and is especially well-suited for use in conjunction with checkpoint inhibitors. Private startup Alloplex is currently funded by angel financing.
How much funding has Alloplex Biotherapeutics raised?
Alloplex Biotherapeutics has raised $21.0M across 2 rounds on record. The most recent is a Series A of $20.0M announced in Feb 2023.
When did Alloplex Biotherapeutics last raise funding?
Alloplex Biotherapeutics' most recent funding round on record is a Series A of $20.0M, announced in Feb 2023.
Who is the CEO of Alloplex Biotherapeutics?
Frank Borriello is listed as CEO at Alloplex Biotherapeutics.
Where is Alloplex Biotherapeutics headquartered?
Alloplex Biotherapeutics is based in Boston, Massachusetts, United States.
How many employees does Alloplex Biotherapeutics have?
Alloplex Biotherapeutics is in the 1-10 employee band.
How does Alloplex Biotherapeutics' funding compare to other Biotechnology startups?
Alloplex Biotherapeutics' latest round of $20.0M is above the $8.0M median round size for Biotechnology companies on FundedIQ across 4,182 tracked companies over the last two years.
About FundedIQ's Alloplex Biotherapeutics Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Alloplex Biotherapeutics is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.
Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.